Data as of Apr 17
| -0.09 / -0.44%|
The 8 analysts offering 12-month price forecasts for BioMed Realty Trust Inc have a median target of 22.50, with a high estimate of 23.00 and a low estimate of 20.00. The median estimate represents a +10.08% increase from the last price of 20.44.
The current consensus among 10 polled investment analysts is to Buy stock in BioMed Realty Trust Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.